It is hypothesized that genomic markers of ancestry may add additional information in the estimation of prostate cancer risk above and beyond other genetic and/or clinical risk markers like prostate specific antigen (PSA) level [12],[13]. This evidence concerns the gene KLK3 and prostate carcinoma.